K A Malle Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -99.73%
(FY 2023)
- Profit -214.72%
(FY 2023)
- Ebitda -112.25%
(FY 2023)
- Net Worth -110.91%
(FY 2023)
- Total Assets -1.33%
(FY 2023)
About K A Malle Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Bhomavat and Divyakumar Jain serve as directors at the Company.
- CIN/LLPIN
U74120MH2011PTC220679
- Company No.
220679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at K A Malle Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Bhomavat  | Director | 08-Aug-2011 | Current |
| Divyakumar Jain | Director | 10-Aug-2015 | Current |
Financial Performance of K A Malle Life Sciences.
K A Malle Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.73% decrease. The company also saw a substantial fall in profitability, with a 214.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 110.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K A Malle Life Sciences?
Unlock access to K A Malle Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Sai-Ashray Industries LimitedActive 29 years 4 months
Rahul Bhomavat and Divyakumar Jain are mutual person
- K. A. Malle Pharmaceuticals LimitedActive 42 years 7 months
Rahul Bhomavat and Divyakumar Jain are mutual person
- Nautilus Infotech Private LimitedActive 13 years 4 months
Rahul Bhomavat and Divyakumar Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at K A Malle Life Sciences?
Unlock and access historical data on people associated with K A Malle Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K A Malle Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K A Malle Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
